In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination., Coppola, Mariateresa , NPJ Vaccines, 2021 Jun 03, Volume 6, Issue 1, (2021)

Allergic Asthma Favors  Growth in the Lungs of Infected Mice., Machelart, Arnaud, Potemberg Georges, Van Maele Laurye, Demars Aurore, Lagneaux Maxime, De Trez Carl, Sabatel Catherine, Bureau Fabrice, De Prins Sofie, Percier Pauline, et al. , Front Immunol, 2018, Volume 9, (2018)

Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice., Roupie, Virginie, Pidot Sacha J., Einarsdottir Tobba, Van den Poel Christophe, Jurion Fabienne, Stinear Timothy P., and Huygen Kris , PLoS Negl Trop Dis, 2014, Volume 8, Issue 1, p.e2604, (2014)

Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen., Bruffaerts, Nicolas, Romano Marta, Denis Olivier J., Jurion Fabienne, and Huygen Kris , Vaccines (Basel), 2014 Mar 05, Volume 2, Issue 1, Number 195, p.181-95, (2014)

Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis34032, Waeckerle-Men, Y., Bruffaerts Nicolas, Liang Y., Jurion Fabienne, Sander P., Kundig T.M., Huygen K, and Johansen P. , Vaccine, 4/2/2013, Volume 31, Issue 7, Number 1064, p.1057 - 1064, (2013)

Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice1377, Todoroff, J., Lemaire MM., Fillee C., Jurion Fabienne, Renauld J.C., Huygen K, and Vanbever R. , PLoS ONE, 0/0/2013, Volume 8, Issue 5, p.e63344, (2013)

Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c)., Romano, Marta, Rindi Laura, Korf Hannelie, Bonanni Daniela, Adnet Pierre-Yves, Jurion Fabienne, Garzelli Carlo, and Huygen Kris , Vaccine, 2008 Nov 11, Volume 26, Issue 48, p.6053-63, (2008)

Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3., Romano, Marta, Roupie Virginie, Wang Xiao M., Denis Olivier J., Jurion Fabienne, Adnet Pierre-Yves, Laali Rachid, and Huygen Kris , Immunology, 2006 Jul, Volume 118, Issue 3, p.321-32, (2006)

Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv., Romano, Marta, D'Souza Sushila, Adnet Pierre-Yves, Laali Rachid, Jurion Fabienne, Palfliet Kamiel, and Huygen Kris , Vaccine, 2006 Apr 12, Volume 24, Issue 16, p.3353-64, (2006)

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis., D'Souza, S, Rosseels V, Romano Marta, Tanghe A, Denis O, Jurion Fabienne, Castiglione N, Vanonckelen A, Palfliet K, and Huygen Kris , Infect Immun, 2003 Jan, Volume 71, Issue 1, Number 493, p.483-93, (2003)

Improved tuberculosis DNA vaccines by formulation in cationic lipids., D'Souza, S, Rosseels V, Denis O, Tanghe A, De Smet N, Jurion Fabienne, Palfliet K, Castiglioni N, Vanonckelen A, Wheeler C, et al. , Infect Immun, 2002 Jul, Volume 70, Issue 7, Number 3688, p.3681-8, (2002)

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?, Zlotta, A R., Van Vooren J P., Denis Olivier J., Drowart A, Daffé M, Lefèvre P, Schandene L, De Cock M, De Bruyn J, Vandenbussche P, et al. , Int J Cancer, 2000 Sep 15, Volume 87, Issue 6, (2000)

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?, Zlotta, A R., Van Vooren J P., Huygen K, Drowart A, Decock M, Pirson M, Jurion Fabienne, Palfliet K, Denis Olivier J., Simon J, et al. , Eur Urol, 2000 Apr, Volume 37, Issue 4, (2000)

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection., Denis, Olivier J., Tanghe A, Palfliet K, Jurion Fabienne, van den Berg Thierry, Vanonckelen A, Ooms J, Saman E, Ulmer J B., Content J, et al. , Infect Immun, 1998 Apr, Volume 66, Issue 4, p.1527-33, (1998)

Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group., Lozes, E, Denis O, Drowart A, Jurion Fabienne, Palfliet K, Vanonckelen A, De Bruyn J, De Cock M, Van Vooren J P., and Huygen K , Scand J Immunol, 1997 Jul, Volume 46, Issue 1, Number 26, p.16-26, (1997)

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer., Zlotta, A R., Drowart A, Huygen K, De Bruyn J, Shekarsarai H, Decock M, Pirson M, Jurion Fabienne, Palfliet K, Denis Olivier J., et al. , Clin Exp Immunol, 1997 Jul, Volume 109, Issue 1, (1997)

Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG36652, Huygen, K, Lozes E., Gilles B., Drowart A., Palfliet K., Jurion Fabienne, Roland I., Art M., Dufaux M., and Nyabenda J. , Infect.Immun., 0/2/1994, Volume 62, Issue 2, Number 370, p.363 - 370, (1994)